Rare Disease Report

NEOD001 and AL Amyloidosis

JULY 21, 2015

Michaela Liedtke, MD of Stanford University of Medicine discusses the pathophysiology of AL Amyloidosis and how NEOD001 may provide benefit to those patients.

The VITAL Amyloidosis study is currently recruiting patients. To learn more, visit clinicaltrials.gov/ct2/show/NCT02312206

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.